NASDAQ: SLN
Silence Therapeutics PLC Stock Forecast, Predictions & Price Target

Analyst price target for SLN

Based on 2 analysts offering 12 month price targets for Silence Therapeutics PLC

Min Forecast
$20.00+1.73%
Avg Forecast
$26.00+32.25%
Max Forecast
$32.00+62.77%

Should I buy or sell SLN stock?

Based on 2 analysts offering ratings for Silence Therapeutics PLC.

Buy
Strong Buy
1 analysts 50%
Buy
0 analysts 0%
Hold
1 analysts 50%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their SLN stock forecasts and price targets.

SLN stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-10-21
lockedlocked$00.00+00.00%2026-08-11Find Out Why

1 of 1

SLN vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
SLN$19.66$26.00+32.25%Buy
AKTS$16.76$36.67+118.78%Strong Buy
SVRA$4.54$12.00+164.32%Strong Buy
MGTX$9.77$21.00+114.94%Buy
ODTX$19.08$35.33+85.18%Strong Buy

Silence Therapeutics Stock Forecast FAQ

Is Silence Therapeutics Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: SLN) stock is to Buy SLN stock.

Out of 2 analysts, 1 (50%) are recommending SLN as a Strong Buy, 0 (0%) are recommending SLN as a Buy, 1 (50%) are recommending SLN as a Hold, 0 (0%) are recommending SLN as a Sell, and 0 (0%) are recommending SLN as a Strong Sell.

If you're new to stock investing, here's how to buy Silence Therapeutics stock.

What is SLN's Price Target?

According to 2 Wall Street analysts that have issued a 1 year SLN price target, the average SLN price target is $26.00, with the highest SLN stock price forecast at $32.00 and the lowest SLN stock price forecast at $20.00.

On average, Wall Street analysts predict that Silence Therapeutics's share price could reach $26.00 by Oct 21, 2027. The average Silence Therapeutics stock price prediction forecasts a potential upside of 32.25% from the current SLN share price of $19.66.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.